Our “one-stop-shop” next-generation drug repurposing platform (CloudScreen) was presented in NODES 22, Neo4j Online Developer Education Summit. During the online advanced session, technology transfer took place by co-speakers and project members; S. Ouzounis, V. Panagiotopoulos, and A. Kanterakis. The scope of CloudScreen was presented along with its competitive advantage including algorithmic features concerning Machine Learning and Artificial Intelligence. Participants from around the world had the opportunity to be introduced to CloudScreen and the usage of Artificial Intelligence in drug repurposing.